Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease

被引:119
|
作者
Abautret-Daly, Aine [1 ,2 ]
Dempsey, Elaine [1 ,2 ]
Parra-Blanco, Adolfo [3 ]
Medina, Carlos [3 ,4 ]
Harkin, Andrew [1 ,2 ]
机构
[1] Trinity Coll Dublin, Inst Neurosci, Neuropsychopharmacol Res Grp, Dublin, Ireland
[2] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland
[3] Hosp Cent Asturias, Dept Gastroenterol, Oviedo, Spain
[4] Trinity Coll Dublin, Trinity Biosci Inst, Dublin, Ireland
来源
ACTA NEUROPSYCHIATRICA | 2018年 / 30卷 / 05期
基金
欧盟第七框架计划; 爱尔兰科学基金会;
关键词
anxiety; colitis; depression; gut-brain axis; inflammatory bowel disease; QUALITY-OF-LIFE; DEXTRAN SULFATE SODIUM; FECAL MICROBIOTA TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; ULCERATIVE-COLITIS; CROHNS-DISEASE; RISK-FACTORS; PSYCHOLOGICAL STRESS; BARRIER PERMEABILITY; RECEPTOR EXPRESSION;
D O I
10.1017/neu.2017.3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
IntroductionInflammatory bowel disease (IBD) is a chronic relapsing and remitting disorder characterised by inflammation of the gastrointestinal tract. There is a growing consensus that IBD is associated with anxiety- and depression-related symptoms. Psychological symptoms appear to be more prevalent during active disease states with no difference in prevalence between Crohn's disease and ulcerative colitis. Behavioural disturbances including anxiety- and depression-like symptoms have also been observed in animal models of IBD.ResultsThe likely mechanisms underlying the association are discussed with particular reference to communication between the gut and brain. The close bidirectional relationship known as the gut-brain axis includes neural, hormonal and immune communication links. Evidence is provided for a number of interacting factors including activation of the inflammatory response system in the brain, the hypothalamic-pituitary-adrenal axis, and brain areas implicated in altered behaviours, changes in blood brain barrier integrity, and an emerging role for gut microbiota and response to probiotics in IBD.DiscussionThe impact of psychological stress in models of IBD remains somewhat conflicted, however, it is weighted in favour of stress or early stressful life events as risk factors in the development of IBD, stress-induced exacerbation of inflammation and relapse.ConclusionIt is recommended that patients with IBD be screened for psychological disturbance and treated accordingly as intervention can improve quality of life and may reduce relapse rates.
引用
收藏
页码:275 / 296
页数:22
相关论文
共 50 条
  • [1] Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review
    Dubinsky, Marla C.
    Dotan, Iris
    Rubin, David T.
    Bernauer, Mark
    Patel, Dipen
    Cheung, Raymond
    Modesto, Irene
    Latymer, Mark
    Keefer, Laurie
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (09) : 985 - 997
  • [2] Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut-brain communications
    Ge, Li
    Liu, Shuman
    Li, Sha
    Yang, Jing
    Hu, Guangran
    Xu, Changqing
    Song, Wengang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
    Kim, Min Chul
    Jung, Yoon Suk
    Song, Young Seok
    Lee, Jung In
    Park, Jung Ho
    Sohn, Chong Il
    Choi, Kyu Yong
    Park, Dong Il
    GUT AND LIVER, 2016, 10 (03) : 399 - 405
  • [4] Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability
    Chan, Webber
    Shim, Hang Hock
    Lim, Miao Shan
    Sawadjaan, Fatimin Leila Bahjin
    Isaac, Sangeetha Poongunam
    Chuah, Sai Wei
    Leong, Rupert
    Kong, Chris
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (12) : 1314 - 1319
  • [5] Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach
    Collins, Stephen M.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (04) : 493 - 501
  • [6] A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease
    Tse, Chung Sang
    Singh, Siddharth
    Sandborn, William J.
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (05) : 788 - 800
  • [7] The impact of anxiety and depression on relapse in patients with inflammatory bowel disease
    Vidal, Angela
    Gomez-Gil, Esther
    Sans, Miquel
    Portella, Maria J.
    Salamero, Manel
    Pique, Josep M.
    Panes, Julian
    MEDICINA CLINICA, 2009, 132 (08): : 298 - 302
  • [8] Influences and Impact of Anxiety and Depression in the Setting of Inflammatory Bowel Disease
    Navabi, Seyedehsan
    Gorrepati, Venkata Subhash
    Yadav, Sanjay
    Chintanaboina, Jaykrishna
    Maher, Sarah
    Demuth, Peter
    Stern, Benjamin
    Stuart, August
    Tinsley, Andrew
    Clarke, Kofi
    Williams, Emmanuelle D.
    Coates, Matthew D.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2303 - 2308
  • [9] Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease
    Narula, Neeraj
    Pinto-Sanchez, Maria Ines
    Calo, Natalia Causada
    Ford, Alexander C.
    Bercik, Premsyl
    Reinisch, Walter
    Moayyedi, Paul
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (07) : 1255 - 1261
  • [10] The Gut Microbiome in Patients with Anxiety, Depression and Inflammatory Bowel Disease
    Anglin, Rebecca
    Libertucci, Josie
    Wolfe, Melanie
    Lee, Christine
    Moayyedi, Paul
    Surette, Michael
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S289 - S289